Reply Does Direct Transcatheter Aortic Valve Replacement Increase the Risk of Cerebral Embolization? by Bijuklic, Klaudija & Schofer, Joachim
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 9 , N O . 3 , 2 0 1 6 Letters to the Editor
F E B R U A R Y 8 , 2 0 1 6 : 2 9 9 – 3 0 4
303Finally, the authors have only shown an associa-
tion between direct TAVR and an increased volume of
cerebral ischemic lesions. Because the overall number
of lesions is not increased, and given the aforemen-
tioned issues, we feel that a title stating that there is
an increased risk of cerebral embolization without
prior balloon valvuloplasty in TAVR is potentially
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after implantation of a balloon-expandable aortic valve without prior balloon
valvuloplasty. J Am Coll Cardiol Intv 2015;8:1608–13.REPLY: Does Direct Transcatheter Aortic
Valve Replacement Increase the
Risk of Cerebral Embolization?TABLE 1 Cerebral DW-MRI
TAVI With
BAV
(n ¼ 32)
TAVI Without
BAV
(n ¼ 55) p Value
Incidence, % 59.4 70.9 0.27
Number of ischemic lesions 1.8  2.4 2.2  2.7 0.39
Volume of ischemic lesions,
mm3
89.5  128.2 235.4  331.4 0.01
Values are mean  SD. The incidence in % is deﬁned as the number of patients
with cerebral ischemic lesions divided by the total number of the patients multi-
plied by 100.
BAV ¼ balloon aortic valvuloplasty; DW-MRI ¼ diffusion-weighted magnetic
resonance imaging; TAVR ¼ transcatheter aortic valve replacement.We thank Dr. Palmer and colleagues for their interest
in our work (1) and appreciate their comments.
As mentioned in the discussion section of our
paper, one major limitation of the study is the retro-
spective design with a small number of patients.
The Edwards SAPIEN 3 (Edwards Lifesciences,
Irvine, California) with its smaller proﬁle (16- and
18-F) may allow the treatment of patients with
smaller, more calciﬁed peripheral arteries compared
with the Edwards SAPIEN XT (18- and 21-F). Periph-
eral artery disease, however, which is the main limi-
tation for the transfemoral approach, was well
balanced between the 2 groups (21.8% in trans-
catheter aortic valve replacement [TAVR] with
balloon aortic valvuloplasty [BAV], 20.0% in TAVR
without BAV; p ¼ 0.75).
In Table 1, the baseline characteristics of patients
undergoing TAVR with BAV were compared with
TAVR without BAV. There was a numerical but not
statistically signiﬁcant difference in atrial ﬁbrillation
(28.1% vs. 34.5%; p ¼ 0.7), diabetes (15.6% vs. 27.3%;
p ¼ 0.7), and arterial hypertension (73.3% vs. 81.8%;p ¼ 0.3) between the 2 groups. These are known
risk factors for stroke but not necessarily for cerebral
ischemic lesions post-TAVR. In a recent study,
Samim et al. (2) analyzed risk factors for post-TAVR
cerebral diffusion weighted-magnetic resonance
imaging lesions in a cohort of 276 patients. Indepen-
dent predictors for the number or volume of cerebral
lesions were age, hyperlipidemia, post-dilation and
peak transaortic gradient. In our study, age in the
TAVR without BAV group was numerically even
lower (82.9  6.8 years vs. 83.8  5.2 years;
p ¼ 0.81) and hyperlipidemia was comparable (50%
vs. 50.9%; p ¼ 0.8). When patients with post-
dilation were excluded (5 of 87) from the analysis,
the difference in mean volume of ischemic lesions
between the 2 groups remained statistically signiﬁ-
cant (243.4  334.9 mm3 for TAVR without BAV and
79.7  117.4 mm3 for TAVR with BAV; p ¼ 0.006).
Thus, differences in baseline characteristic do not
seem to explain our ﬁndings.
Aortic and aortic valve calciﬁcation might affect the
cardiac magnetic resonance ﬁndings. Unfortunately,
we do not have data on the degree of aortic/valve
calciﬁcation. However, transthoracic echocardiogra-
phy data, including transvalvular gradient, effective
oriﬁce area, and mean transvalvular gradient, were
comparable in both groups.
Detailed data of the incidence, number, and
volume of ischemic lesions are found in Table 1.
We disagree that it would be appropriate to
change the title of our paper to “Increased Volume
of Cerebral Ischemic Lesions After Implantation of a
Balloon-Expandable Aortic Valve Without Prior
Balloon Valvuloplasty.” Indeed, former studies have
demonstrated that not lesion number but lesion
volume on diffusion-weighted magnetic resonance
imaging correlates signiﬁcantly with clinical
outcome ratings (3). This makes sense, because the
volume includes single large as well as multiple
smaller lesions.
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